Trial Profile
Enhance the Metabolic Profile of Women With Insulin Resistance: Carbohydrate Modified Diet Alone and in Combination With Metformin or Metformin Plus Avandia in Non-Diabetic Women With Midlife Weight Gain and Documented Insulin Elevations (Syndrome W)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary) ; Metformin
- Indications Insulin resistance
- Focus Pharmacodynamics
- Acronyms EMPOWIR
- 04 Apr 2016 Results of gynoid fat ratio at 12 months presented at The 98th Annual Meeting of the Endocrine Society
- 26 Jun 2012 Results presented at the 94th Annual Meeting of the Endocrine Society.
- 28 Jun 2011 New trial record